1,560
Views
4
CrossRef citations to date
0
Altmetric
Clinical Study

Emotional management and biological markers of dietetic regimen in chronic kidney disease patients

ORCID Icon, ORCID Icon, ORCID Icon, , , , , , , & ORCID Icon show all
Pages 173-178 | Received 26 Jul 2016, Accepted 27 Oct 2016, Published online: 15 Nov 2016

References

  • Schieppati A, Remuzzi G. Chronic renal diseases as a public health problem: Epidemiology, social, and economic implications. Kidney Int Suppl. 2005;68:S7–S10.
  • Christensen AJ, Ehlers SL. Psychological factors in end-stage renal disease: An emerging context for behavioral medicine research. J Consult Clin Psychol. 2002;70:712–724.
  • García-Llana H, Remor E, Selgas R. Adherence to treatment, emotional state and quality of life in patients with end-stage renal disease undergoing dialysis. Psicothema. 2013;25:79–86.
  • Merkus MP, Jager KJ, Dekker FW, Boeschoten EW, Stevens P, Krediet RT. Quality of life in patients on chronic dialysis: Self-assessment 3 months after the start of treatment. The Necosad Study Group. Am J Kidney Dis. 1997;29:584–592.
  • Calia R, Lai C, Aceto P, et al. Preoperative psychological factors predicting graft rejection in patients undergoing kidney transplant: A pilot study. Transpl Proc. 2011;43:1006–1009.
  • Calia R, Lai C, Aceto P, et al. Emotional management and quality of life in mother living versus multi-organ donor renal transplant recipients. J Health Psychol. 2015. [Epub ahead of print]. doi: 10.1177/1359105315604378.
  • Calia R, Lai C, Aceto P, et al. Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: Results from a preliminary cross-sectional study. Physiol Behav. 2015;142:152–154.
  • Wu AW, Fink NE, Marsh-Manzi JV, et al. Changes in quality of life during hemodialysis and peritoneal dialysis treatment: Generic and disease specific measures. J Am Soc Nephrol. 2004;15:743–753.
  • Cameron JI, Whiteside C, Katz J, Devins GM. Differences in quality of life across renal replacement therapies: A meta-analytic comparison. Am J Kidney Dis. 2000;35:629–637.
  • Fukunishi I, Maeda K, Kubota M, Tomino Y. Association of alexithymia with low utilization and perception on a measure of social support in patients on peritoneal dialysis. Psychol Rep. 1997;80:127–130.
  • Kojima M, Hayano J, Suzuki S, et al. Depression, alexithymia and long-term mortality in chronic hemodialysis patients. Psychother Psychosom. 2010;79:303–311.
  • DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–2107.
  • Griva K, Lai AY, Lim HA, Yu Z, Foo MW, Newman SP. Non-adherence in patients on peritoneal dialysis: A systematic review. PLoS One. 2014;9:e89001.
  • Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483.
  • Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith–Hamilton Pleasure Scale. Br J Psychiatry. 1995;167:99–103.
  • Parker JD, Taylor GJ, Bagby RM. The 20-Item Toronto Alexithymia Scale. III. Reliability and factorial validity in a community population. J Psychosom Res. 2003;55:269–275.
  • Levey AS, Inker LA, Coresh J. GFR estimation: From physiology to public health. Am J Kidney Dis. 2014;63:820–834.
  • Oreopoulos DG, Thodis E, Passadakis P, Vargemezis V. Home dialysis as a first option: A new paradigm. Int Urol Nephrol. 2009;41:595–605.
  • Theofilou P. Noncompliance with medical regimen in haemodialysis treatment: A case study. Case Rep Nephrol. 2011;2011:476038.
  • Calia R, Lai C, Aceto P, et al. Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: Preliminary results. Ren Fail. 2015;37:678–680.
  • Calia R, Lai C, Aceto P, et al. Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation. Transpl Proc. 2011;43:1020–1023.
  • Eriksson D, Goldsmith D, Teitsson S, Jackson J, van Nooten F. Cross-sectional survey in CKD patients across Europe describing the association between quality of life and anaemia. BMC Nephrol. 2016;17:97.
  • Lai C, Aceto P, Luciani M, et al. Externally oriented thinking predicts phosphorus levels in dialyzed patients. Transpl Proc. 2016;48:309–310.
  • Zoccali C, Ruggenenti P, Perna A, et al. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. J Am Soc Nephrol. 2011;22:1923–1930.
  • Chang AR, Grams ME. Serum phosphorus and mortality in the Third National Health and Nutrition Examination Survey (NHANES III): Effect modification by fasting. Am J Kidney Dis. 2014;64:567–573.
  • Yamamoto KT, Robinson-Cohen C, de Oliveira MC, et al. Dietary phosphorus is associated with greater left ventricular mass. Kidney Int. 2013;83:707–714.
  • Newsome B, Ix JH, Tighiouart H, et al. Effect of protein restriction on serum and urine phosphate in the modification of diet in renal disease (MDRD) study. Am J Kidney Dis. 2013;61:1045–1046.
  • Patel SS, Peterson RA, Kimmel PL. The impact of social support on end-stage renal disease. Semin Dial. 2005;18:98–102.
  • Lam LW, Lee DT, Shiu AT. The dynamic process of adherence to a renal therapeutic regimen: Perspectives of patients undergoing continuous ambulatory peritoneal dialysis. Int J Nurs Stud. 2014;51:908–916.
  • Fukunishi I, Saito S, Ozaki S. The influence of defense mechanisms on secondary alexithymia in hemodialysis patients. Psychother Psychosom. 1992;57:50–56.